Fact CheckerSign in

NCT07847086Not yet recruiting

Gait Pattern and Its Relation to Cognition and VEP in Multiple Sclerosis

Pattern of Gait and Assessment Regarding Pathophysiology and Mechanism and Its Relation to Cognition, VEP, and Radiology as Prediction of Progression of Disease in Multiple Sclerosis Patients

Source: ClinicalTrials.gov · Last updated 1 Oct 2026

Brief summary (registry, in English)

This cross-sectional study aims to assess the pattern of gait in patients with multiple sclerosis and to evaluate its relation to cognitive function, visual evoked potentials, and radiological findings.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
70 (estimated)
First submitted
23 Sept 2026
Start date
26 Sept 2026
Primary completion date
26 Sept 2027
Lead sponsor
Assiut University
NCT number
NCT07847086

What you commit to

  • Study type: Observational
  • Planned participants: 70
  • From 26 Sept 2026 to the primary completion date, 26 Sept 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Other neurological, orthopedic, visual, or vestibular conditions affecting gait
  • Severe cognitive impairment precluding valid testing
  • Ocular disease unrelated to multiple sclerosis

Other

  • Pregnancy
  • MRI contraindications

Who the study is looking for

  • \- Age 18 to 55 years
  • Confirmed diagnosis of multiple sclerosis according to the revised McDonald criteria
  • Clinically stable (no relapse or steroid treatment within 4 weeks)
  • Able to walk independently with or without a single assistive device
  • Written informed consent

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.